Partial ORF1ab gene target failure in clinical SARS-CoV-2 testing identifies BA.2.12.1 variant samples
Unique construction of a point-of-care rapid antigen test using two pairs of monoclonal antibodies has led to good performance that remained durable across multiple variants in laboratory and clinical evaluations. Test should identify almost all individuals harboring infectious SARS-CoV-2.
Importance: Alterations to the saliva microbiome based on SARS-CoV-2 viral load indicate potential biologically relevant bacterial-viral relationships which may affect clinical outcomes in COVID-19 disease.
SARS-CoV-2 viral persistence in a solid organ transplant recipient
We report the emergence of the SARS-CoV-2 variant lineage Iota (B.1.526) in New York City in early 2021
Genomic and wastewater surveillance of SARS-CoV-2.
Genomic and wastewater surveillance of SARS-CoV-2.
SARS-CoV-2 RT-PCR Ct value and duration of symptoms may be useful in risk stratification of patients with COVID-19.
Increased CPE detection in patients with COVID-19 may signal a re-emergence of these highly resistant pathogens in the wake of the global pandemic. Increased surveillance and antimicrobial stewardship efforts will be needed to mitigate their future impact.